LAVA Medtech Acquisition (LAVA Medtech Acquisition) EV-to-Revenue : (As of Jun. 22, 2024)

View and export this data going back to 2021. Start your Free Trial

What is LAVA Medtech Acquisition EV-to-Revenue?

EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, LAVA Medtech Acquisition's enterprise value is $0.00 Mil. LAVA Medtech Acquisition's Revenue for the trailing twelve months (TTM) ended in Dec. 2022 was $0.00 Mil. Therefore, LAVA Medtech Acquisition's EV-to-Revenue for today is .

The historical rank and industry rank for LAVA Medtech Acquisition's EV-to-Revenue or its related term are showing as below:

LVACW's EV-to-Revenue is not ranked ^*
in the Diversified Financial Services industry.
Industry Median: 4.18
* Ranked among companies with meaningful EV-to-Revenue only.

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

As of today (2024-06-22), LAVA Medtech Acquisition's stock price is $0.01. LAVA Medtech Acquisition's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2022 was $0.00. Therefore, LAVA Medtech Acquisition's PS Ratio for today is .

LAVA Medtech Acquisition EV-to-Revenue Historical Data

The historical data trend for LAVA Medtech Acquisition's EV-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

LAVA Medtech Acquisition EV-to-Revenue Chart

LAVA Medtech Acquisition Annual Data

Trend

Dec21

Dec22

EV-to-Revenue

LAVA Medtech Acquisition Quarterly Data
	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22
EV-to-Revenue	Get a 7-Day Free Trial			-	-	-	-	-

Competitive Comparison of LAVA Medtech Acquisition's EV-to-Revenue

For the Shell Companies subindustry, LAVA Medtech Acquisition's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

LAVA Medtech Acquisition's EV-to-Revenue Distribution in the Diversified Financial Services Industry

For the Diversified Financial Services industry and Financial Services sector, LAVA Medtech Acquisition's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where LAVA Medtech Acquisition's EV-to-Revenue falls into.

LAVA Medtech Acquisition EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

LAVA Medtech Acquisition's EV-to-Revenue for today is calculated as:

EV-to-Revenue	=	Enterprise Value (Today)	/	Revenue (TTM)
	=	0.000	/	0
	=

LAVA Medtech Acquisition's current Enterprise Value is $0.00 Mil.
LAVA Medtech Acquisition's Revenue for the trailing twelve months (TTM) ended in Dec. 2022 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00 Mil.

LAVA Medtech Acquisition (NAS:LVACW) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

LAVA Medtech Acquisition's PS Ratiofor today is calculated as:

PS Ratio	=	Share Price (Today)	/	Revenue per Share (TTM)
	=	0.01	/
	=

LAVA Medtech Acquisition's share price for today is $0.01.
LAVA Medtech Acquisition's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2022 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00.

LAVA Medtech Acquisition EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of LAVA Medtech Acquisition's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.